Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idex (IEX) Asset Writedowns and Impairment (2019 - 2025)

Historic Asset Writedowns and Impairment for Idex (IEX) over the last 7 years, with Q3 2025 value amounting to $100000.0.

  • Idex's Asset Writedowns and Impairment changed N/A to $100000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $800000.0, marking a year-over-year increase of 16666.67%. This contributed to the annual value of $100000.0 for FY2024, which is 8750.0% down from last year.
  • Latest data reveals that Idex reported Asset Writedowns and Impairment of $100000.0 as of Q3 2025.
  • In the past 5 years, Idex's Asset Writedowns and Impairment ranged from a high of $16.8 million in Q3 2022 and a low of $100000.0 during Q1 2021
  • In the last 5 years, Idex's Asset Writedowns and Impairment had a median value of $250000.0 in 2022 and averaged $1.9 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first skyrocketed by 270000.0% in 2022, then crashed by 9821.43% in 2023.
  • Quarter analysis of 5 years shows Idex's Asset Writedowns and Impairment stood at $600000.0 in 2021, then crashed by 33.33% to $400000.0 in 2022, then dropped by 25.0% to $300000.0 in 2023, then plummeted by 66.67% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
  • Its Asset Writedowns and Impairment was $100000.0 in Q3 2025, compared to $600000.0 in Q2 2025 and $100000.0 in Q4 2024.